427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma

by Mohammed Milhem, Yousef Zakharia, Jayanshu Jain, Melanie Frees, Hesham Yasin, Jaime Bonner, Michele Freesmeier, Rohan Garje, Vyshak Alva Venur
Published 2020-11-01